Skip to main content
Subscribe
Register
Sign in
Membership
Insights
Events
About
Subscribe
Register
Sign in
Premium
Alternative Insight and Premium Journalism
Latest Articles
Premium
The Hedge Funds Behind the Biopharma IPO Bonanza
Stephen Taub
January 21, 2021
Premium
Jamie Sterne’s Skye Global Finished 2020 With a Bang
Stephen Taub
January 20, 2021
Premium
Dinakar Singh’s Axon Surges to Huge Gains
Stephen Taub
January 19, 2021
Premium
Lesser-Known Tiger Seed Launches Long-Only Fund
Stephen Taub
January 19, 2021
Premium
Sacerdote’s Whale Rock Posts Best-Ever Year
Stephen Taub
January 19, 2021
Premium
SkyBridge’s Comeback Accelerated — But It Still Ended 2020 With a Loss
Michelle Celarier
January 19, 2021
Premium
The Tiger-Related Funds That Reaped Their Biggest Gains Ever in 2020
Stephen Taub
January 14, 2021
Premium
Health Care IPOs Boost Viking’s Hybrid Fund
Stephen Taub
January 12, 2021
Premium
These Macro Managers Had Record Years
Stephen Taub
January 11, 2021
Premium
Caxton Posts Its Best Year Since Andrew Law Took Control
Stephen Taub
January 11, 2021
Premium
Hindenburg Snags Half of Top-Ten Short Activist Calls of 2020
Michelle Celarier
January 11, 2021
Premium
The New Hedge Fund That Surged 200 Percent in 2020
Stephen Taub
January 11, 2021
Premium
Bridgewater Funds Rebounded in 2020 — But Two of Its Biggest Funds Are Still Negative
Stephen Taub
January 7, 2021
Premium
Discovery Capital Posts Best Gains in Years
Stephen Taub
January 7, 2021
Premium
Citadel, Millennium, Other Multistrats Posted Best Gains in Years in 2020
Stephen Taub
January 6, 2021
Premium
Third Point Staged a Big Turnaround in 2020
Stephen Taub
January 6, 2021
Premium
Hedge Funds Featured Prominently in 2020 SPAC Boom
Stephen Taub
January 4, 2021
Premium
The Stocks That Drove Glenview’s Major Comeback
Stephen Taub
January 4, 2021
More Articles